glp-1 leaky gut Glucagon-like peptide-1 (GLP-1) receptor agonists in inflammatory bowel disease: mechanisms, clinical implications, and therapeutic potential a) GLP-1R mediated decrease in

Make sure your medication supply bridges the gap when you return to the United States

While we dont prescribe these medications, we can: Perform regular neuropathy assessments (e.g., monofilament testing, vibration perception) to track changes in sensation over time

Following guidance from your healthcare provider and slowly increasing your dose could help to reduce these side effects

Xu D, Nair A, Sigston C, et al

Effect of the GLP-1 receptor agonist exenatide on pro-inflammatory and metabolic biomarkers in individuals with alcohol use disorder

In September 2025, the FDA reported instances of compounded GLP-1 products containing unapproved foreign substances and companies selling drugs to consumers that were falsely labeled for research purposes. A 2024 report also found that many active pharmaceutical ingredients for compounded GLP-1s were imported from unregistered foreign suppliers, raising questions about supply chain oversight